Viewing Study NCT01662869


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2025-12-26 @ 5:05 AM
Study NCT ID: NCT01662869
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2012-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module